CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,504 | +39.1% | 2,400 | +118.2% | 0.00% | – |
| Q2 2023 | $2,519 | +151.6% | 1,100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,001 | – | 1,100 | +1000.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +66.7% | 1,100 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 1,100 | +10.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |